Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1628416-28-3
2. Fdl169
3. Cftr Corrector 2
4. 49pn4s4fdh
5. 2(1h)-phthalazineacetamide, 7-ethoxy-4-(3-fluorophenyl)-n-methyl-n-(2-methyl-6-benzoxazolyl)-1-oxo-
6. 2-(7-ethoxy-4-(3-fluorophenyl)-1-oxophthalazin-2(1h)-yl)-n-methyl-n-(2-methylbenzo(d)oxazol-6-yl)acetamide
7. 2-[7-ethoxy-4-(3-fluorophenyl)-1-oxo-1,2-dihydrophthalazin-2-yl]-n-methyl-n-(2-methyl-1,3-benzoxazol-6-yl)acetamide
8. 2-[7-ethoxy-4-(3-fluorophenyl)-1-oxophthalazin-2-yl]-n-methyl-n-(2-methyl-1,3-benzoxazol-6-yl)acetamide
9. 7-ethoxy-4-(3-fluorophenyl)-n-methyl-n-(2-methyl-6-benzoxazolyl)-1-oxo-2(1h)-phthalazineacetamide
10. Cftr Corrector 2?
11. Unii-49pn4s4fdh
12. Schembl16048480
13. Fdl-169
14. Bdbm160525
15. Fdl-169;fdl 169
16. Bcp30546
17. Ex-a3163
18. S8795
19. Zb1606
20. Akos037515658
21. Sb18874
22. Hy-125381
23. Cs-0091038
24. Us9682969, 17
25. Us9682969, 22
| Molecular Weight | 486.5 g/mol |
|---|---|
| Molecular Formula | C27H23FN4O4 |
| XLogP3 | 4.6 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 6 |
| Exact Mass | 486.17033339 g/mol |
| Monoisotopic Mass | 486.17033339 g/mol |
| Topological Polar Surface Area | 88.2 Ų |
| Heavy Atom Count | 36 |
| Formal Charge | 0 |
| Complexity | 856 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
15
PharmaCompass offers a list of FDL169 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right FDL169 manufacturer or FDL169 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred FDL169 manufacturer or FDL169 supplier.
PharmaCompass also assists you with knowing the FDL169 API Price utilized in the formulation of products. FDL169 API Price is not always fixed or binding as the FDL169 Price is obtained through a variety of data sources. The FDL169 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A FDL169 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of FDL169, including repackagers and relabelers. The FDA regulates FDL169 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. FDL169 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A FDL169 supplier is an individual or a company that provides FDL169 active pharmaceutical ingredient (API) or FDL169 finished formulations upon request. The FDL169 suppliers may include FDL169 API manufacturers, exporters, distributors and traders.
FDL169 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of FDL169 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right FDL169 GMP manufacturer or FDL169 GMP API supplier for your needs.
A FDL169 CoA (Certificate of Analysis) is a formal document that attests to FDL169's compliance with FDL169 specifications and serves as a tool for batch-level quality control.
FDL169 CoA mostly includes findings from lab analyses of a specific batch. For each FDL169 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
FDL169 may be tested according to a variety of international standards, such as European Pharmacopoeia (FDL169 EP), FDL169 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (FDL169 USP).
